Team:Yale/Results
From 2014.igem.org
Line 143: | Line 143: | ||
<i><strong>Figure 1.</strong> Preliminary gel screening of Mach 1 strains containing transformed pZE21_A12C_T7RNA plasmids created via Gibson Assembly.</i></center></p> | <i><strong>Figure 1.</strong> Preliminary gel screening of Mach 1 strains containing transformed pZE21_A12C_T7RNA plasmids created via Gibson Assembly.</i></center></p> | ||
- | <img src="https://static.igem.org/mediawiki/2014/f/f2/Yale_sequences_1.png"> | + | <center><img src="https://static.igem.org/mediawiki/2014/f/f2/Yale_sequences_1.png"></center> |
<p> | <p> | ||
Line 156: | Line 156: | ||
Experimental plan for the GFP fluorescence assay testing the efficacy of the T7 riboregulation system. The T7 riboregulation system, pZE21_A12C_T7RNA, would express sfGFP behind a T7 promoter, in the plasmid pZA21. Either plasmid, and both plasmids together, were transformed into ECNR2 and induced with either IPTG and ATC. ECNR2 is the ancestral strain. A positive control was the same pZA21_T7sfGFP plasmid in ECNR2, and the same T7 RNA polymerase gene inserted in a regular pZE21 plasmid with a pLtetO promoter, and a negative control with the pZA21_T7sfGFP in ECNR2 without any plasmid that contains T7 RNA.</p> | Experimental plan for the GFP fluorescence assay testing the efficacy of the T7 riboregulation system. The T7 riboregulation system, pZE21_A12C_T7RNA, would express sfGFP behind a T7 promoter, in the plasmid pZA21. Either plasmid, and both plasmids together, were transformed into ECNR2 and induced with either IPTG and ATC. ECNR2 is the ancestral strain. A positive control was the same pZA21_T7sfGFP plasmid in ECNR2, and the same T7 RNA polymerase gene inserted in a regular pZE21 plasmid with a pLtetO promoter, and a negative control with the pZA21_T7sfGFP in ECNR2 without any plasmid that contains T7 RNA.</p> | ||
- | <img src="https://static.igem.org/mediawiki/2014/f/ff/Yale_figure8.png"> | + | <center><img src="https://static.igem.org/mediawiki/2014/f/ff/Yale_figure8.png"></center> |
<p> | <p> | ||
Line 162: | Line 162: | ||
<i><strong>Figure 3.</strong> The functionalities behind the GFP assay.</i></center></p> | <i><strong>Figure 3.</strong> The functionalities behind the GFP assay.</i></center></p> | ||
- | <img src="https://static.igem.org/mediawiki/2014/0/03/Yale_figure9.png"> | + | <center><img src="https://static.igem.org/mediawiki/2014/0/03/Yale_figure9.png"></center> |
<p> | <p> | ||
Line 169: | Line 169: | ||
- | <img src="https://static.igem.org/mediawiki/2014/3/37/Yale_table_1.png"> | + | <center><img src="https://static.igem.org/mediawiki/2014/3/37/Yale_table_1.png"></center> |
<p> | <p> |
Revision as of 03:08, 18 October 2014
Results |
|||||||||||
T7 Riboregulation System
| |||||||||||
Adhesion Testing
|